{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:22:08Z","timestamp":1788538928211,"version":"build-2803163510"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012295","name":"NIHR Newcastle Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012295","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Dementia with Lewy bodies (DLB) is a common yet underdiagnosed neurodegenerative dementia, characterised neuropathologically by nigrostriatal dopaminergic degeneration and widespread \u03b1-synuclein aggregation. Clinical diagnosis remains challenging due to marked heterogeneity in presentation and substantial overlap with Alzheimer\u2019s disease (AD), resulting in diagnostic delays and frequent misdiagnosis. The ability to identify underlying pathological processes ante-mortem is essential to improve diagnostic accuracy, refine prognosis, stratify patients for clinical trials, and ultimately enable personalised therapeutic approaches. Over recent decades, major advances have been made in the development of neuroimaging biomarkers that reflect key features in Lewy body disease pathology, many of which have informed diagnostic criteria. In addition to dopaminergic dysfunction and \u03b1-synuclein pathology, co-existing neuropathologies including amyloid-\u03b2, tau, neuroinflammation, and vascular changes are increasingly recognised as important modifiers of clinical phenotype and disease trajectory in DLB. This review summarises the current landscape of neuroimaging modalities in DLB and critically examines their relationships with confirmed neuropathological correlates. We discuss indicative biomarkers such as striatal dopamine imaging and\n                    <jats:sup>123<\/jats:sup>\n                    I-metaiodobenzylguanidine myocardial scintigraphy, alongside supportive imaging markers derived from structural magnetic resonance imaging and Fluorodeoxyglucose Positron Emission Tomography (FDG-PET). Emerging PET approaches targeting \u03b1-synuclein, as well as established amyloid and tau-PET techniques for assessing co-pathologies, are reviewed in the context of post-mortem validation studies. Finally, we consider Translocator protein PET imaging as a marker of neuroinflammation and highlight key methodological limitations and knowledge gaps. Together, these neuroimaging\u2013pathological correlations provide critical insights into disease mechanisms and outline future directions toward earlier, biologically informed diagnosis and precision medicine in DLB.\n                  <\/jats:p>","DOI":"10.1007\/s00702-026-03237-6","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T15:04:02Z","timestamp":1784300642000},"page":"1805-1815","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neuropathological correlates of imaging in dementia with Lewy bodies"],"prefix":"10.1007","volume":"133","author":[{"given":"Lauren","family":"Walker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Attems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Donaghy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"issue":"3","key":"3237_CR1","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1176\/jnp.13.3.374","volume":"13","author":"D Aarsland","year":"2001","unstructured":"Aarsland D, Ballard C, McKeith I, Perry RH, Larsen JP (2001) Comparison of extrapyramidal signs in dementia with Lewy bodies and Parkinson\u2019s disease. J Neuropsychiatry Clin Neurosci 13(3):374\u2013379","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"1","key":"3237_CR2","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41398-020-00954-8","volume":"10","author":"J Amin","year":"2020","unstructured":"Amin J, Holmes C, Dorey RB, Tommasino E, Casal YR, Williams DM, Dupuy C, Nicoll JAR, Boche D (2020) Neuroinflammation in dementia with Lewy bodies: a human post-mortem study. Transl Psychiatry 10(1):267","journal-title":"Transl Psychiatry"},{"issue":"6","key":"3237_CR3","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1212\/WNL.0000000000001834","volume":"85","author":"LL Barnes","year":"2015","unstructured":"Barnes LL, Leurgans S, Aggarwal NT, Shah RC, Arvanitakis Z, James BD, Buchman AS, Bennett DA, Schneider JA (2015) Mixed pathology is more likely in black than white decedents with Alzheimer dementia. Neurology 85(6):528\u2013534","journal-title":"Neurology"},{"issue":"1","key":"3237_CR4","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1212\/WNL.45.1.182","volume":"45","author":"G Becker","year":"1995","unstructured":"Becker G, Seufert J, Bogdahn U, Reichmann H, Reiners K (1995) Degeneration of substantia nigra in chronic Parkinson\u2019s disease visualized by transcranial color-coded real-time sonography. Neurology 45(1):182\u2013184","journal-title":"Neurology"},{"issue":"6","key":"3237_CR5","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1001\/archneur.59.6.999","volume":"59","author":"D Berg","year":"2002","unstructured":"Berg D, Roggendorf W, Schroder U, Klein R, Tatschner T, Benz P, Tucha O, Preier M, Lange KW, Reiners K, Gerlach M, Becker G (2002) Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch Neurol 59(6):999\u20131005","journal-title":"Arch Neurol"},{"issue":"7","key":"3237_CR6","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.neurobiolaging.2010.12.015","volume":"33","author":"EJ Burton","year":"2012","unstructured":"Burton EJ, Mukaetova-Ladinska EB, Perry RH, Jaros E, Barber R, O\u2019Brien (2012) Neuropathological correlates of volumetric MRI in autopsy-confirmed Lewy body dementia. Neurobiol Aging 33(7):1228\u20131236","journal-title":"Neurobiol Aging"},{"key":"3237_CR7","doi-asserted-by":"publisher","first-page":"104000","DOI":"10.1016\/j.nicl.2026.104000","volume":"50","author":"E Capogna","year":"2026","unstructured":"Capogna E, Venturi G, Motta L, Manners DN, Braghittoni D, Guidi L, Baldelli L, Calandra-Buonaura G, Sambati L, Venneri A, Tonon C, Mitolo M, Lodi R (2026) The role of quantitative susceptibility mapping in dementia with Lewy Bodies. Neuroimage Clin 50:104000","journal-title":"Neuroimage Clin"},{"issue":"1","key":"3237_CR8","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41380-024-02656-9","volume":"30","author":"F Chauveau","year":"2025","unstructured":"Chauveau F, Winkeler A, Chalon S, Boutin H, Becker G (2025) PET imaging of neuroinflammation: any credible alternatives to TSPO yet? Mol Psychiatry 30(1):213\u2013228","journal-title":"Mol Psychiatry"},{"issue":"8","key":"3237_CR9","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S1474-4422(12)70142-4","volume":"11","author":"CM Clark","year":"2012","unstructured":"Clark CM, Pontecorvo MJ, Beach TG, Bedell BJ, Coleman RE, Doraiswamy PM, Fleisher AS, Reiman EM, Sabbagh MN, Sadowsky CH, Schneider JA, Arora A, Carpenter AP, Flitter ML, Joshi AD, Krautkramer MJ, Lu M, Mintun MA, Skovronsky DM (2012) Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-beta plaques: a prospective cohort study. Lancet Neurol 11(8):669\u2013678","journal-title":"Lancet Neurol"},{"issue":"Pt 9","key":"3237_CR10","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1093\/brain\/aws211","volume":"135","author":"SJ Colloby","year":"2012","unstructured":"Colloby SJ, McParland S, O\u2019Brien JT, Attems J (2012) Neuropathological correlates of dopaminergic imaging in Alzheimer\u2019s disease and Lewy body dementias. Brain 135(Pt 9):2798\u20132808","journal-title":"Brain"},{"issue":"2","key":"3237_CR11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/ana.25392","volume":"85","author":"D Coughlin","year":"2019","unstructured":"Coughlin D, Xie SX, Liang M, Williams A, Peterson C, Weintraub D, McMillan CT, Wolk DA, Akhtar RS, Hurtig HI, Branch Coslett H, Hamilton RH, Siderowf AD, Duda JE, Rascovsky K, Lee EB, Lee VM, Grossman M, Trojanowski JQ, Irwin DJ (2019) Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders. Ann Neurol 85(2):259\u2013271","journal-title":"Ann Neurol"},{"issue":"10","key":"3237_CR12","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.30265","volume":"40","author":"P Diaz-Galvan","year":"2025","unstructured":"Diaz-Galvan P, Przybelski SA, Lesnick TG, Murray ME, Nguyen A, Reichard RR, Dickson DW, Ono D, Senjem ML, Schwarz CG, Gunter J, Lowe V, Forsberg LK, Fields JA, Savica R, Graff-Radford J, Ramanan VK, Jones D, Botha H, St Louis EK, Knopman D, Day GS, Graff-Radford N, Kremers W, Petersen RC, Jack CR Jr., Ferman TJ, Boeve BF, Kantarci K (2025) Substantia Nigra Iron deposition in Lewy body disease: a magnetic resonance imaging and neuropathology study. Mov Disord 40(10):2129\u20132138","journal-title":"Mov Disord"},{"issue":"7","key":"3237_CR13","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1002\/mds.27403","volume":"33","author":"PC Donaghy","year":"2018","unstructured":"Donaghy PC, Firbank MJ, Thomas AJ, Lloyd J, Petrides G, Barnett N, Olsen K, O\u2019Brien (2018) Clinical and imaging correlates of amyloid deposition in dementia with Lewy bodies. Mov Disord 33(7):1130\u20131138","journal-title":"Mov Disord"},{"issue":"5","key":"3237_CR14","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.jagp.2019.12.009","volume":"28","author":"PC Donaghy","year":"2020","unstructured":"Donaghy PC, Firbank MJ, Thomas AJ, Lloyd J, Petrides G, Barnett N, Olsen K, O\u2019Brien (2020) Amyloid Imaging and Longitudinal Clinical Progression in Dementia With Lewy Bodies. Am J Geriatric Psychiatry 28(5):573\u2013577","journal-title":"Am J Geriatric Psychiatry"},{"issue":"15","key":"3237_CR15","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1016\/j.neuron.2024.05.006","volume":"112","author":"H Endo","year":"2024","unstructured":"Endo H, Ono M, Takado Y, Matsuoka K, Takahashi M, Tagai K, Kataoka Y, Hirata K, Takahata K, Seki C, Kokubo N, Fujinaga M, Mori W, Nagai Y, Mimura K, Kumata K, Kikuchi T, Shimozawa A, Mishra SK, Yamaguchi Y, Shimizu H, Kakita A, Takuwa H, Shinotoh H, Shimada H, Kimura Y, Ichise M, Suhara T, Minamimoto T, Sahara N, Kawamura K, Zhang MR, Hasegawa M, Higuchi M (2024) Imaging alpha-synuclein pathologies in animal models and patients with Parkinson\u2019s and related diseases. Neuron 112(15):2540\u20132557 e2548","journal-title":"Neuron"},{"issue":"1","key":"3237_CR16","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3233\/JAD-180992","volume":"68","author":"TJ Filshtein","year":"2019","unstructured":"Filshtein TJ, Dugger BN, Jin LW, Olichney JM, Farias ST, Carvajal-Carmona L, Lott P, Mungas D, Reed B, Beckett LA, DeCarli C (2019) Neuropathological Diagnoses of Demented Hispanic, Black, and Non-Hispanic White Decedents Seen at an Alzheimer\u2019s Disease Center. J Alzheimers Dis 68(1):145\u2013158","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"3237_CR17","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.parkreldis.2010.03.007","volume":"16","author":"JE Galvin","year":"2010","unstructured":"Galvin JE, Duda JE, Kaufer DI, Lippa CF, Taylor A, Zarit SH (2010) Lewy body dementia: the caregiver experience of clinical care. Parkinsonism Relat Disord 16(6):388\u2013392","journal-title":"Parkinsonism Relat Disord"},{"key":"3237_CR18","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.parkreldis.2020.10.016","volume":"81","author":"MP Giannoccaro","year":"2020","unstructured":"Giannoccaro MP, Donadio V, Giannini G, Devigili G, Rizzo G, Incensi A, Cason E, Calandra-Buonaura G, Eleopra R, Cortelli P, Liguori R (2020) Comparison of 123I-MIBG scintigraphy and phosphorylated alpha-synuclein skin deposits in synucleinopathies. Parkinsonism Relat Disord 81:48\u201353","journal-title":"Parkinsonism Relat Disord"},{"issue":"9","key":"3237_CR20","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1212\/WNL.0000000000000734","volume":"83","author":"J Graff-Radford","year":"2014","unstructured":"Graff-Radford J, Murray ME, Lowe VJ, Boeve BF, Ferman TJ, Przybelski SA, Lesnick TG, Senjem ML, Gunter JL, Smith GE, Knopman DS, Jack CR Jr., Dickson DW, Petersen RC, Kantarci K (2014) Dementia with Lewy bodies: basis of cingulate island sign. Neurology 83(9):801\u2013809","journal-title":"Neurology"},{"issue":"1","key":"3237_CR19","doi-asserted-by":"publisher","first-page":"fcaa040","DOI":"10.1093\/braincomms\/fcaa040","volume":"2","author":"J Graff-Radford","year":"2020","unstructured":"Graff-Radford J, Lesnick TG, Savica R, Chen Q, Ferman TJ, Przybelski SA, Jones DT, Senjem ML, Gunter JL, Kremers WK, Jack CR Jr., Lowe VJ, Petersen RC, Knopman DS, Boeve BF, Murray ME, Dickson DW, Kantarci K (2020) (18)F-fluorodeoxyglucose positron emission tomography in dementia with Lewy bodies. Brain Commun 2(1):fcaa040","journal-title":"Brain Commun"},{"issue":"4","key":"3237_CR21","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, Khoury JE, Landreth GE, Brosseron F, Feinstein DL, Jacobs AH, Wyss-Coray T, Vitorica J, Ransohoff RM, Herrup K, Frautschy SA, Finsen B, Brown GC, Verkhratsky A, Yamanaka K, Koistinaho J, Latz E, Halle A, Petzold GC, Town T, Morgan D, Shinohara ML, Perry VH, Holmes C, Bazan NG, Brooks DJ, Hunot S, Joseph B, Deigendesch N, Garaschuk O, Boddeke E, Dinarello CA, Breitner JC, Cole GM, Golenbock DT, Kummer MP (2015) Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol 14(4):388\u2013405","journal-title":"Lancet Neurol"},{"key":"3237_CR22","doi-asserted-by":"crossref","unstructured":"Heneka MT, van der Flier WM, Jessen F, Hoozemanns J, Thal DR, Boche D, Brosseron F, Teunissen C, Zetterberg H, Jacobs AH, Edison P, Ramirez A, Cruchaga C, Lambert JC, Laza AR, Sanchez-Mut JV, Fischer A, Castro-Gomez S, Stein TD, Kleineidam L, Wagner M, Neher JJ, Cunningham C, Singhrao SK, Prinz M, Glass CK, Schlachetzki JCM, Butovsky O, Kleemann K, De Jaeger PL, Scheiblich H, Brown GC, Landreth G, Moutinho M, Grutzendler J, Gomez-Nicola D, McManus RM, Andreasson K, Ising C, Karabag D, Baker DJ, Liddelow SA, Verkhratsky A, Tansey M, Monsonego A, Aigner L, Dorothee G, Nave KA, Simons M, Constantin G, Rosenzweig N, Pascual A, Petzold GC, Kipnis J, Venegas C, Colonna M, Walter J, Tenner AJ, O\u2019Banion MK, Steinert JR, Feinstein DL, Sastre M, Bhaskar K, Hong S, Schafer DP, Golde T, Ransohoff RM, Morgan D, Breitner J, R. Mancuso and S. P., Riechers (2025) Neuroinflammation in Alzheimer disease. Nat Rev Immunol 25(5): 321\u2013352","DOI":"10.1038\/s41577-024-01104-7"},{"key":"3237_CR23","doi-asserted-by":"crossref","unstructured":"Hosseini SA, Servaes S, Macedo AC, Aumont E, Rahmouni N, Chan T, Therriault J, Trudel L, Hall B, Wang YT, Arias JF, Bezgin G, Zheng Y, Goncalves MP, Quispialaya Socualaya K, Woo MS, Tissot C, Oliva-Lopez D, Li J, Mitchell S, Lebrun A, Hopewell R, Chawla S, Fonov V, Massarweh G, Medina YI, Soucy JP, Montembeault M, Vitali P, Blennow K, Karikari TK, Benedet AL, Ashton NJ, Zetterberg H, Pascoal TA, Gauthier S, Klostranec J, Zhuang H, Cho J, Collins DL, Wang Y, Rudko DA (2026) and P. Rosa-Neto Quantitative susceptibility mapping of the brain is associated with inflammatory changes in Alzheimer\u2019s disease related areas. J Cereb Blood Flow Metab: 271678X261417193","DOI":"10.1177\/0271678X261417193"},{"issue":"4","key":"3237_CR24","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/bpa.12182","volume":"25","author":"DR Howlett","year":"2015","unstructured":"Howlett DR, Whitfield D, Johnson M, Attems J, O\u2019Brien JT, Aarsland D, Lai MK, Lee JH, Chen C, Ballard C, Hortobagyi T, Francis PT (2015) Regional Multiple Pathology Scores are Associated with Cognitive Decline in Lewy Body Dementias. Brain Pathol 25(4):401\u2013408","journal-title":"Brain Pathol"},{"issue":"Pt 6","key":"3237_CR25","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1093\/brain\/awn016","volume":"131","author":"MD Ikonomovic","year":"2008","unstructured":"Ikonomovic MD, Klunk WE, Abrahamson EE, Mathis CA, Price JC, Tsopelas ND, Lopresti BJ, Ziolko S, Bi W, Paljug WR, Debnath ML, Hope CE, Isanski BA, Hamilton RL, DeKosky ST (2008) Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer\u2019s disease. Brain 131(Pt 6):1630\u20131645","journal-title":"Brain"},{"key":"3237_CR27","unstructured":"Irwin DJ, Hurtig HI (2018) The Contribution of Tau, Amyloid-Beta and Alpha-Synuclein Pathology to Dementia in Lewy Body Disorders. J Alzheimers Dis Parkinsonism 8(4)"},{"issue":"1","key":"3237_CR26","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S1474-4422(16)30291-5","volume":"16","author":"DJ Irwin","year":"2017","unstructured":"Irwin DJ, Grossman M, Weintraub D, Hurtig HI, Duda JE, Xie SX, Lee EB, Van Deerlin VM, Lopez OL, Kofler JK, Nelson PT, Jicha GA, Woltjer R, Quinn JF, Kaye J, Leverenz JB, Tsuang D, Longfellow K, Yearout D, Kukull W, Keene CD, Montine TJ, Zabetian CP, Trojanowski JQ (2017) Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis. Lancet Neurol 16(1):55\u201365","journal-title":"Lancet Neurol"},{"issue":"4","key":"3237_CR28","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1159\/000327360","volume":"31","author":"KA Jellinger","year":"2011","unstructured":"Jellinger KA, Attems J (2011) Prevalence and pathology of dementia with Lewy bodies in the oldest old: a comparison with other dementing disorders. Dement Geriatr Cogn Disord 31(4):309\u2013316","journal-title":"Dement Geriatr Cogn Disord"},{"key":"3237_CR29","doi-asserted-by":"crossref","unstructured":"Jie C, Treyer V, Schibli R, Mu L (2021) Tauvid\u2122: The First FDA-Approved PET Tracer for Imaging Tau Pathology in Alzheimer\u2019s Disease. Pharmaceuticals (Basel) 14(2)","DOI":"10.3390\/ph14020110"},{"issue":"1","key":"3237_CR30","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/jnen\/nlz109","volume":"79","author":"M Kameyama","year":"2020","unstructured":"Kameyama M, Iizuka T (2020) The Limitation of Evaluating Cingulate Island Sign by SPECTAuthors\u2019 Reply. J Neuropathol Exp Neurol 79(1):118\u2013119","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"3237_CR31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13195-018-0350-6","volume":"10","author":"JPM Kane","year":"2018","unstructured":"Kane JPM, Surendranathan A, Bentley A, Barker SAH, Taylor JP, Thomas AJ, Allan LM, McNally RJ, James PW, McKeith IG, Burn DJ, O\u2019Brien (2018) Clinical prevalence of Lewy body dementia. Alzheimers Res Ther 10(1):19","journal-title":"Alzheimers Res Ther"},{"issue":"6","key":"3237_CR32","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1212\/WNL.0b013e31826357a5","volume":"79","author":"K Kantarci","year":"2012","unstructured":"Kantarci K, Ferman TJ, Boeve BF, Weigand SD, Przybelski S, Vemuri P, Murray ME, Senjem ML, Smith GE, Knopman DS, Petersen RC, Jack CR Jr., Parisi JE, Dickson DW (2012) Focal atrophy on MRI and neuropathologic classification of dementia with Lewy bodies. Neurology 79(6):553\u2013560","journal-title":"Neurology"},{"issue":"1","key":"3237_CR33","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/ana.24825","volume":"81","author":"K Kantarci","year":"2017","unstructured":"Kantarci K, Lowe VJ, Boeve BF, Senjem ML, Tosakulwong N, Lesnick TG, Spychalla AJ, Gunter JL, Fields JA, Graff-Radford J, Ferman TJ, Jones DT, Murray ME, Knopman DS, Jack CR Jr., Petersen RC (2017) AV-1451 tau and beta-amyloid positron emission tomography imaging in dementia with Lewy bodies. Ann Neurol 81(1):58\u201367","journal-title":"Ann Neurol"},{"key":"3237_CR34","doi-asserted-by":"crossref","unstructured":"Kantarci K, Lowe VJ, Chen Q, Przybelski SA, Lesnick TG, Schwarz CG, Senjem ML, Gunter JL, Jack CR Jr., Graff-Radford J, Jones DT, Knopman DS, Graff-Radford N, Ferman TJ, Parisi JE, Dickson DW, Petersen RC, Boeve BF, Murray ME (2020) beta-Amyloid PET and neuropathology in dementia with Lewy bodies. Neurology 94(3): e282\u2013e291","DOI":"10.1212\/WNL.0000000000008818"},{"issue":"4","key":"3237_CR35","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1136\/jnnp-2017-317134","volume":"89","author":"E King","year":"2018","unstructured":"King E, O\u2019Brien JT, Donaghy P, Morris C, Barnett N, Olsen K, Martin-Ruiz C, Taylor JP, Thomas AJ (2018) Peripheral inflammation in prodromal Alzheimer\u2019s and Lewy body dementias. J Neurol Neurosurg Psychiatry 89(4):339\u2013345","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"14","key":"3237_CR36","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1002\/mds.25975","volume":"29","author":"J Kraemmer","year":"2014","unstructured":"Kraemmer J, Kovacs GG, Perju-Dumbrava L, Pirker S, Traub-Weidinger T, Pirker W (2014) Correlation of striatal dopamine transporter imaging with post mortem substantia nigra cell counts. Mov Disord 29(14):1767\u20131773","journal-title":"Mov Disord"},{"issue":"4","key":"3237_CR37","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00401-007-0336-0","volume":"115","author":"T Lashley","year":"2008","unstructured":"Lashley T, Holton JL, Gray E, Kirkham K, O\u2019Sullivan SS, Hilbig A, Wood NW, Lees AJ, Revesz T (2008) Cortical alpha-synuclein load is associated with amyloid-beta plaque burden in a subset of Parkinson\u2019s disease patients. Acta Neuropathol 115(4):417\u2013425","journal-title":"Acta Neuropathol"},{"issue":"1","key":"3237_CR38","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40478-016-0315-6","volume":"4","author":"VJ Lowe","year":"2016","unstructured":"Lowe VJ, Curran G, Fang P, Liesinger AM, Josephs KA, Parisi JE, Kantarci K, Boeve BF, Pandey MK, Bruinsma T, Knopman DS, Jones DT, Petrucelli L, Cook CN, Graff-Radford NR, Dickson DW, Petersen RC, Jack CR Jr., Murray ME (2016) An autoradiographic evaluation of AV-1451 Tau PET in dementia. Acta Neuropathol Commun 4(1):58","journal-title":"Acta Neuropathol Commun"},{"issue":"6","key":"3237_CR39","first-page":"1096","volume":"36","author":"KG Lurie","year":"1995","unstructured":"Lurie KG, Dae MW, Dutton J, Velazquez-Rocha SJ, O\u2019Connell (1995) Metaiodobenzylguanidine as an index of atrioventricular nodal adrenergic activity. J Nucl Med 36(6):1096\u20131101","journal-title":"J Nucl Med"},{"issue":"3","key":"3237_CR40","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s00702-024-02856-1","volume":"132","author":"AK Luyken","year":"2025","unstructured":"Luyken AK, Lappe C, Viard R, Lohle M, Kleinlein HR, Kuchcinski G, Langner S, Wenzel AM, Walter M, Weber MA, Storch A, Devos D, Walter U (2025) High correlation of quantitative susceptibility mapping and echo intensity measurements of nigral iron overload in Parkinson\u2019s disease. J Neural Transm (Vienna) 132(3):407\u2013417","journal-title":"J Neural Transm (Vienna)"},{"key":"3237_CR41","doi-asserted-by":"crossref","unstructured":"Mak E, Nicastro N, Malpetti M, Savulich G, Surendranathan A, Holland N, Passamonti L, Jones PS, Carter SF, Su L, Hong YT, Fryer TD, Williams GB, Aigbirhio F, Rowe JB (2021) and J. T. O\u2019Brien Imaging tau burden in dementia with Lewy bodies using [(18)F]-AV1451 positron emission tomography. Neurobiol Aging 101: 172\u2013180","DOI":"10.1016\/j.neurobiolaging.2020.11.006"},{"issue":"6","key":"3237_CR42","doi-asserted-by":"publisher","first-page":"830","DOI":"10.2967\/jnumed.121.263694","volume":"63","author":"M Malpetti","year":"2022","unstructured":"Malpetti M, Joie RL, Rabinovici GD (2022) Tau beats amyloid in predicting brain atrophy in Alzheimer disease: implications for prognosis and clinical trials. J Nucl Med 63(6):830\u2013832","journal-title":"J Nucl Med"},{"issue":"16","key":"3237_CR43","doi-asserted-by":"publisher","first-page":"e1648","DOI":"10.1212\/WNL.0000000000200110","volume":"98","author":"T Matsubara","year":"2022","unstructured":"Matsubara T, Kameyama M, Tanaka N, Sengoku R, Orita M, Furuta K, Iwata A, Arai T, Maruyama H, Saito Y, Murayama S (2022) Autopsy Validation of the Diagnostic Accuracy of (123)I-Metaiodobenzylguanidine Myocardial Scintigraphy for Lewy Body Disease. Neurology 98(16):e1648\u2013e1659","journal-title":"Neurology"},{"issue":"7","key":"3237_CR44","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1002\/alz.12291","volume":"17","author":"KE McAleese","year":"2021","unstructured":"McAleese KE, Colloby SJ, Thomas AJ, Al-Sarraj S, Ansorge O, Neal J, Roncaroli F, Love S, Francis PT, Attems J (2021) Concomitant neurodegenerative pathologies contribute to the transition from mild cognitive impairment to dementia. Alzheimer\u2019s Dement 17(7):1121\u20131133","journal-title":"Alzheimer\u2019s Dement"},{"issue":"4","key":"3237_CR45","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S1474-4422(07)70057-1","volume":"6","author":"I McKeith","year":"2007","unstructured":"McKeith I, O\u2019Brien J, Walker Z, Tatsch K, Booij J, Darcourt J, Padovani A, Giubbini R, Bonuccelli U, Volterrani D, Holmes C, Kemp P, Tabet N, Meyer I, Reininger C, Group DLBS (2007) Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurol 6(4):305\u2013313","journal-title":"Lancet Neurol"},{"key":"3237_CR46","doi-asserted-by":"crossref","unstructured":"McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, Bayston A, Beach TG, Blanc F, Bohnen N, Bonanni L, Bras J, Brundin P, Burn D, Chen-Plotkin A, Duda JE, El-Agnaf O, Feldman H, Ferman TJ, Ffytche D, Fujishiro H, Galasko D, Goldman JG, Gomperts SN, Graff-Radford NR, Honig LS, Iranzo A, Kantarci K, Kaufer D, Kukull W, Lee VMY, Leverenz JB, Lewis S, Lippa C, Lunde A, Masellis M, Masliah E, McLean P, Mollenhauer B, Montine TJ, Moreno E, Mori E, Murray M, O\u2019Brien JT, Orimo S, Postuma RB, Ramaswamy S, Ross OA, Salmon DP, Singleton A, Taylor A, Thomas A, Tiraboschi P, Toledo JB, J. Q., Trojanowski D, Tsuang Z, Walker M, Yamada, Kosaka K (2017) Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology 89(1): 88\u2013100","DOI":"10.1212\/WNL.0000000000004058"},{"issue":"19","key":"3237_CR47","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1212\/01.wnl.0000435299.57153.f0","volume":"81","author":"ME Murray","year":"2013","unstructured":"Murray ME, Ferman TJ, Boeve BF, Przybelski SA, Lesnick TG, Liesinger AM, Senjem ML, Gunter JL, Preboske GM, Lowe VJ, Vemuri P, Dugger BN, Knopman DS, Smith GE, Parisi JE, Silber MH, Graff-Radford NR, Petersen RC, Jack CR Jr., Dickson DW, Kantarci K (2013) MRI and pathology of REM sleep behavior disorder in dementia with Lewy bodies. Neurology 81(19):1681\u20131689","journal-title":"Neurology"},{"key":"3237_CR48","doi-asserted-by":"crossref","unstructured":"Nedelska Z, Ferman TJ, Boeve BF, Przybelski SA, Lesnick TG, Murray ME, Gunter JL, Senjem ML, Vemuri P, Smith GE, Geda YE, Graff-Radford J, Knopman DS, Petersen RC, Parisi JE, Dickson DW, Jack CR, Jr. and, Kantarci K (2014) Pattern of brain atrophy rates in autopsy-confirmed dementia with Lewy bodies. Neurobiol Aging","DOI":"10.1212\/WNL.82.10_supplement.S48.004"},{"issue":"5","key":"3237_CR49","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/NEN.0b013e31825018f7","volume":"71","author":"PT Nelson","year":"2012","unstructured":"Nelson PT, Alafuzoff I, Bigio EH, Bouras C, Braak H, Cairns NJ, Castellani RJ, Crain BJ, Davies P, Del Tredici K, Duyckaerts C, Frosch MP, Haroutunian V, Hof PR, Hulette CM, Hyman BT, Iwatsubo T, Jellinger KA, Jicha GA, Kovari E, Kukull WA, Leverenz JB, Love S, Mackenzie IR, Mann DM, Masliah E, McKee AC, Montine TJ, Morris JC, Schneider JA, Sonnen JA, Thal DR, Trojanowski JQ, Troncoso JC, Wisniewski T, Woltjer RL, Beach TG (2012) Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropathol Exp Neurol 71(5):362\u2013381","journal-title":"J Neuropathol Exp Neurol"},{"key":"3237_CR50","doi-asserted-by":"crossref","unstructured":"Oppedal K, Ferreira D, Cavallin L, Lemstra AW, Ten Kate M, Padovani A, Rektorova I, Bonanni L, Wahlund LO, Engedal K, Nobili F, Kramberger M, Taylor JP, Hort J, Snaedal J, Blanc F, Walker Z, Antonini A, Westman E, Aarsland D (2019) and I. Alzheimer\u2019s Disease Neuroimaging A signature pattern of cortical atrophy in dementia with Lewy bodies: A study on 333 patients from the European DLB consortium. Alzheimers Dement 15(3): 400\u2013409","DOI":"10.1016\/j.jalz.2018.09.011"},{"issue":"11","key":"3237_CR51","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1001\/jama.2018.12917","volume":"320","author":"R Ossenkoppele","year":"2018","unstructured":"Ossenkoppele R, Rabinovici GD, Smith R, Cho H, Sch\u00f6ll M, Strandberg O, Palmqvist S, Mattsson N, Janelidze S, Santillo A, Ohlsson T, J\u00f6gi J, Tsai R, La Joie R, Kramer J, Boxer AL, Gorno-Tempini ML, Miller BL, Choi JY, Ryu YH, Lyoo CH, Hansson O (2018) Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders. JAMA 320(11):1151\u20131162","journal-title":"JAMA"},{"issue":"1","key":"3237_CR52","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13024-019-0306-8","volume":"14","author":"TF Outeiro","year":"2019","unstructured":"Outeiro TF, Koss DJ, Erskine D, Walker L, Kurzawa-Akanbi M, Burn D, Donaghy P, Morris C, Taylor JP, Thomas A, Attems J, McKeith I (2019) Dementia with Lewy bodies: an update and outlook. Mol Neurodegener 14(1):5","journal-title":"Mol Neurodegener"},{"key":"3237_CR53","doi-asserted-by":"publisher","first-page":"136399","DOI":"10.1016\/j.neulet.2021.136399","volume":"770","author":"DG Park","year":"2022","unstructured":"Park DG, Kang J, An YS, Chang J, Yoon JH (2022) Association of plasma alpha-synuclein with cardiac (123)I-MIBG scintigraphy in early Parkinson\u2019s disease. Neurosci Lett 770:136399","journal-title":"Neurosci Lett"},{"issue":"8","key":"3237_CR54","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1093\/jnen\/nlz047","volume":"78","author":"L Patterson","year":"2019","unstructured":"Patterson L, Firbank MJ, Colloby SJ, Attems J, Thomas AJ, Morris CM (2019) Neuropathological Changes in Dementia With Lewy Bodies and the Cingulate Island Sign. J Neuropathol Exp Neurol 78(8):717\u2013724","journal-title":"J Neuropathol Exp Neurol"},{"issue":"Suppl 2","key":"3237_CR55","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.2967\/jnumed.124.268756","volume":"66","author":"GD Rabinovici","year":"2025","unstructured":"Rabinovici GD, Knopman DS, Arbizu J, Benzinger TLS, Donohoe KJ, Hansson O, Herscovitch P, Kuo PH, Lingler JH, Minoshima S, Murray ME, Price JC, Salloway SP, Weber CJ, Carrillo MC, Johnson KA (2025) Updated Appropriate Use Criteria for Amyloid and Tau PET: A Report from the Alzheimer\u2019s Association and Society for Nuclear Medicine and Molecular Imaging Workgroup. J Nucl Med 66(Suppl 2):S5\u2013S31","journal-title":"J Nucl Med"},{"issue":"S4","key":"3237_CR56","doi-asserted-by":"publisher","first-page":"e054952","DOI":"10.1002\/alz.054952","volume":"17","author":"AM Racine","year":"2021","unstructured":"Racine AM, Rajagovindan R, Collins JA, Kong J, Li Y, O\u2019Gorman J, Jones S, Graham D, Ratti E, Shulman M (2021) Baseline biomarker (tau PET) characteristics from TANGO: A phase 2 trial of gosuranemab (BIIB092) in early Alzheimer\u2019s disease. Alzheimer\u2019s Dement 17(S4):e054952","journal-title":"Alzheimer\u2019s Dement"},{"issue":"5","key":"3237_CR57","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s00702-023-02630-9","volume":"130","author":"P Riederer","year":"2023","unstructured":"Riederer P, Nagatsu T, Youdim MBH, Wulf M, Dijkstra JM, Sian-Huelsmann J (2023) Lewy bodies, iron, inflammation and neuromelanin: pathological aspects underlying Parkinson\u2019s disease. J Neural Transm (Vienna) 130(5):627\u2013646","journal-title":"J Neural Transm (Vienna)"},{"issue":"12","key":"3237_CR58","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1038\/s43587-023-00523-w","volume":"3","author":"M Shulman","year":"2023","unstructured":"Shulman M, Kong J, O\u2019Gorman J, Ratti E, Rajagovindan R, Viollet L, Huang E, Sharma S, Racine AM, Czerkowicz J, Graham D, Li Y, Hering H, Haeberlein SB (2023) TANGO: a placebo-controlled randomized phase 2 study of efficacy and safety of the anti-tau monoclonal antibody gosuranemab in early Alzheimer\u2019s disease. Nat Aging 3(12):1591\u20131601","journal-title":"Nat Aging"},{"issue":"1","key":"3237_CR59","doi-asserted-by":"publisher","first-page":"10","DOI":"10.2967\/jnmt.125.271835","volume":"54","author":"T Skyles","year":"2026","unstructured":"Skyles T, Bouchal SM, Giarratana A, Wengler J, Hart I, Greig E, Singh H, Huang SS, Martinez F, Nguyen B, Shin CH, Yang M, Parent E, Robb WH, Franceschi AM, Burkett B, Johnson D, Koran ME (2026) PET Imaging in Alzheimer Disease in the Era of Antiamyloid Therapy in the United States: Clinical Utility, Quantification, and Policy Landscape. J Nucl Med Technol 54(1):10\u201317","journal-title":"J Nucl Med Technol"},{"issue":"1","key":"3237_CR60","doi-asserted-by":"publisher","first-page":"6750","DOI":"10.1038\/s41467-023-42305-3","volume":"14","author":"R Smith","year":"2023","unstructured":"Smith R, Capotosti F, Schain M, Ohlsson T, Vokali E, Molette J, Touilloux T, Hliva V, Dimitrakopoulos IK, Puschmann A, Jogi J, Svenningsson P, Andreasson M, Sandiego C, Russell DS, Miranda-Azpiazu P, Halldin C, Stomrud E, Hall S, Bratteby K, E., Luthi-Carter R, Pfeifer A, Kosco-Vilbois M, Streffer J, Hansson O (2023) The alpha-synuclein PET tracer [18F] ACI-12589 distinguishes multiple system atrophy from other neurodegenerative diseases. Nat Commun 14(1):6750 Tampio L\u2019Estrade","journal-title":"Nat Commun"},{"issue":"2","key":"3237_CR61","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1001\/archneurol.2010.357","volume":"68","author":"J Sojkova","year":"2011","unstructured":"Sojkova J, Driscoll I, Iacono D, Zhou Y, Codispoti KE, Kraut MA, Ferrucci L, Pletnikova O, Mathis CA, Klunk WE, O\u2019Brien RJ, Wong DF, Troncoso JC, Resnick SM (2011) In vivo fibrillar beta-amyloid detected using [11\u00a0C]PiB positron emission tomography and neuropathologic assessment in older adults. Arch Neurol 68(2):232\u2013240","journal-title":"Arch Neurol"},{"issue":"3","key":"3237_CR62","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.bbadis.2018.01.008","volume":"1864","author":"N Song","year":"2018","unstructured":"Song N, Wang J, Jiang H, Xie J (2018) Astroglial and microglial contributions to iron metabolism disturbance in Parkinson\u2019s disease. Biochim Biophys Acta Mol Basis Dis 1864(3):967\u2013973","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"3237_CR63","doi-asserted-by":"crossref","unstructured":"Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha-synuclein Lewy bodies Nat 388(6645):839\u2013840","DOI":"10.1038\/42166"},{"issue":"12","key":"3237_CR64","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1093\/brain\/awy265","volume":"141","author":"A Surendranathan","year":"2018","unstructured":"Surendranathan A, Su L, Mak E, Passamonti L, Hong YT, Arnold R, Vazquez Rodriguez P, Bevan-Jones WR, Brain SAE, Fryer TD, Aigbirhio FI, Rowe JB, O\u2019Brien (2018) Early microglial activation and peripheral inflammation in dementia with Lewy bodies. Brain 141(12):3415\u20133427","journal-title":"Brain"},{"issue":"5\u20138","key":"3237_CR65","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13195-014-0077-y","volume":"6","author":"M Swirski","year":"2014","unstructured":"Swirski M, Miners JS, de Silva R, Lashley T, Ling H, Holton J, Revesz T, Love S (2014) Evaluating the relationship between amyloid-beta and alpha-synuclein phosphorylated at Ser129 in dementia with Lewy bodies and Parkinson\u2019s disease. Alzheimers Res Ther 6(5\u20138):77","journal-title":"Alzheimers Res Ther"},{"key":"3237_CR66","unstructured":"Thomas AJ, Attems J, Colloby SJ, O\u2019Brien JT, McKeith I, Walker R, Lee L, Burn D, Lett DJ, Walker Z (2016) Autopsy validation of 123I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB. Neurology"},{"issue":"1","key":"3237_CR67","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13195-018-0356-0","volume":"10","author":"AJ Thomas","year":"2018","unstructured":"Thomas AJ, Mahin-Babaei F, Saidi M, Lett D, Taylor JP, Walker L, Attems J (2018) Improving the identification of dementia with Lewy bodies in the context of an Alzheimer\u2019s-type dementia. Alzheimers Res Ther 10(1):27","journal-title":"Alzheimers Res Ther"},{"issue":"5","key":"3237_CR68","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1212\/WNL.0000000000001204","volume":"84","author":"P Tiraboschi","year":"2015","unstructured":"Tiraboschi P, Attems J, Thomas A, Brown A, Jaros E, Lett DJ, Ossola M, Perry RH, Ramsay L, Walker L, McKeith IG (2015) Clinicians\u2019 ability to diagnose dementia with Lewy bodies is not affected by beta-amyloid load. Neurology 84(5):496\u2013499","journal-title":"Neurology"},{"issue":"5","key":"3237_CR69","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1053\/j.semnuclmed.2011.05.003","volume":"41","author":"S Vallabhajosula","year":"2011","unstructured":"Vallabhajosula S, Nikolopoulou A (2011) Radioiodinated metaiodobenzylguanidine (MIBG): radiochemistry, biology, and pharmacology. Semin Nucl Med 41(5):324\u2013333","journal-title":"Semin Nucl Med"},{"key":"3237_CR70","doi-asserted-by":"crossref","unstructured":"van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, Kanekiyo M, Li D, Reyderman L, Cohen S, Froelich L, Katayama S, Sabbagh M, Vellas B, Watson D, Dhadda S, Irizarry M, Kramer L, Iwatsubo T (2022) Lecanemab in Early Alzheimer\u2019s Disease. The New England Journal of Medicine","DOI":"10.1056\/NEJMoa2212948"},{"key":"3237_CR71","doi-asserted-by":"crossref","unstructured":"van Wetering J, Geut H, Bol JJ, Galis Y, Timmermans E, Twisk JWR, Hepp DH, Morella ML, Pihlstrom L, Lemstra AW, Rozemuller AJM L. E. Jonkman and W. D. J. van de Berg (2025). Correction: Neuroinflammation is associated with Alzheimer\u2019s disease co-pathology in dementia with Lewy bodies. Acta Neuropathol Commun 13(1): 250","DOI":"10.1186\/s40478-025-02169-8"},{"key":"3237_CR72","doi-asserted-by":"crossref","unstructured":"Walker L, Stefanis L, Attems J (2019) Clinical and neuropathological differences between Parkinson\u2019s disease, Parkinson\u2019s disease dementia and dementia with Lewy bodies - current issues and future directions. J Neurochem","DOI":"10.1111\/jnc.14698"},{"issue":"4","key":"3237_CR73","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s00415-005-0023-9","volume":"253","author":"U Walter","year":"2006","unstructured":"Walter U, Dressler D, Wolters A, Wittstock M, Greim B, Benecke R (2006) Sonographic discrimination of dementia with Lewy bodies and Parkinson\u2019s disease with dementia. J Neurol 253(4):448\u2013454","journal-title":"J Neurol"},{"issue":"11","key":"3237_CR74","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1002\/mds.22665","volume":"24","author":"D Weise","year":"2009","unstructured":"Weise D, Lorenz R, Schliesser M, Schirbel A, Reiners K, Classen J (2009) Substantia nigra echogenicity: a structural correlate of functional impairment of the dopaminergic striatal projection in Parkinson\u2019s disease. Mov Disord 24(11):1669\u20131675","journal-title":"Mov Disord"},{"issue":"Pt 3","key":"3237_CR75","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1093\/brain\/awl388","volume":"130","author":"JL Whitwell","year":"2007","unstructured":"Whitwell JL, Weigand SD, Shiung MM, Boeve BF, Ferman TJ, Smith GE, Knopman DS, Petersen RC, Benarroch EE, Josephs KA, Jack CR Jr. (2007) Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer\u2019s disease. Brain 130(Pt 3):708\u2013719","journal-title":"Brain"},{"issue":"6","key":"3237_CR76","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1093\/brain\/awaf078","volume":"148","author":"SS Wijesinghe","year":"2025","unstructured":"Wijesinghe SS, Rowe JB, Mason HD, Allinson KSJ, Thomas R, Vontobel DS, Fryer TD, Hong YT, Bacioglu M, Spillantini MG, van den Ameele J, O\u2019Brien JT, Kaalund S, Malpetti M, Quaegebeur A (2025) Post-mortem validation of in vivo TSPO PET as a microglial biomarker. Brain 148(6):1904\u20131910","journal-title":"Brain"},{"issue":"9","key":"3237_CR77","doi-asserted-by":"publisher","first-page":"e1408","DOI":"10.1002\/ctm2.1408","volume":"13","author":"J Xiang","year":"2023","unstructured":"Xiang J, Zhang Z, Ye K (2023) A promising PET tracer candidate targeting alpha-synuclein inclusions. Clin Transl Med 13(9):e1408","journal-title":"Clin Transl Med"},{"key":"3237_CR78","doi-asserted-by":"publisher","first-page":"1407860","DOI":"10.3389\/fneur.2024.1407860","volume":"15","author":"YY Zhang","year":"2024","unstructured":"Zhang YY, Jiang XH, Zhu PP, Zhuo WY, Liu LB (2024) Advancements in understanding substantia nigra hyperechogenicity via transcranial sonography in Parkinson\u2019s disease and its clinical implications. Front Neurol 15:1407860","journal-title":"Front Neurol"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-026-03237-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-026-03237-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-026-03237-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:02:14Z","timestamp":1788537734000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-026-03237-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":78,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["3237"],"URL":"https:\/\/doi.org\/10.1007\/s00702-026-03237-6","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"assertion":[{"value":"5 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"PCD has received funding from GE Healthcare for an investigator led study involving 123I-FP-CIT SPECT.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}